Alvine Pharmaceuticals, Inc., a biopharmaceutical company focused on developing pharmaceutical products for the treatment of celiac sprue, announced the closing of a $21 million Series A financing.
Early testssuggest therapy with combination of enzymes inactivates gluten in the gut and may benefit patients with celiac disease.
Philadelphia Area doctors teamed with Drexel University Culinary Arts students to create gluten-free delights!
Check the Food Sectionof the 3/23/2006 issue for Dianna Marder's article about celiac disease and dining out.
Opt-in to stay up-to-date on the latest news.
Yes, I want to advance research No, I'd prefer not to
